PRRT2 and cancer: While today we better understand the involvement of individual PKCs in various cancer types and in the context of specific oncogenic alterations, PKC contributions to malignancy remain a challenge, and the relevance of individual PKC isozymes in the progression of human cancer, in many cases, is still a matter of controversy.